Hmgcr Protein — Hmg Coa Reductase plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Hmgcr Protein — Hmg Coa Reductase is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
HMG-CoA reductase (HMGCR) is the rate-limiting enzyme in the mevalonate pathway for cholesterol biosynthesis. It catalyzes the conversion of HMG-CoA to mevalonate. While extensively studied for its role in cardiovascular disease and as the target of statins, HMGCR also plays important roles in brain cholesterol metabolism. In neurons, cholesterol is essential for synaptic vesicle formation, neurotransmitter release, and membrane rafts that host signaling proteins.
| HMGCR | |
|---|---|
| Protein Name | HMG-CoA Reductase |
| Gene | HMGCR |
| UniProt ID | P04035 |
| PDB IDs | 1HMG, 2RBC |
| Molecular Weight | 97 kDa |
| Subcellular Location | Endoplasmic Reticulum membrane |
| Protein Family | HMG-CoA reductase family |
HMGCR is central to maintaining cholesterol homeostasis:
CYP46A1:
HMGCR:
SREBP-2:
Elevated brain cholesterol is associated with increased Aβ production:
| Target | Approach | Status |
|---|---|---|
| CYP46A1 | Activation | Preclinical |
| HMGCR | Statins | Clinical trials |
| SREBP-2 | Modulation | Research |
Hmgcr Protein — Hmg Coa Reductase plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Hmgcr Protein — Hmg Coa Reductase has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Bjorkhem I, et al. (2006). "Cholesterol 24-hydroxylase: an enzyme of cholesterol elimination in the brain." Biochemical and Biophysical Research Communications. DOI:10.1016/j.bbrc.2006.02.114
Carter CJ. (2007). "Alzheimer's disease: APP, gamma-secretase, APOE, LDLR, and cholesterol: a pathological triad?" Journal of Neurochemistry. DOI:10.1111/j.1471-4159.2007.04586.x